Börge Seeger, MLE (Leuven), JSM (Stanford)
- Data protection/cybersecurity
- Life Sciences
- IT and technology law
- Commercial Agreements
Börge Seeger advises on data protection law, cybersecurity, technology law, commercial agreements, e-commerce, outsourcing, distribution law as well as on all IP/IT and carve-out issues in the context of M&A transactions. Furthermore, he represents national and international clients on IP issues with a particular focus on the commercialization of IP rights and know-how.
In addition, Börge Seeger has many years of experience in advising and representing clients in the life sciences/healthcare sector. He regularly advises biotechnology companies, drug and medical device manufacturers on complex M&A deals and product sales, licensing agreements, R&D collaborations, clinical trials, distribution collaborations, as well as on numerous other issues related to the development, manufacturing and marketing of their products. At NEUWERK, he leads the life sciences focus group.
Börge Seeger is an attorney and Certified Licensing Professional (CLP). He is a member of the German-American Lawyers Association (DAJV), the German Society for Legal Informatics (DGRI), the Licensing Executive Society (LES) and the German Association for Intellectual Property and Copyright (GRUR). He is a Fellow at the Center for Internet and Society at Stanford Law School and regularly speaks on privacy, biotechnology, and other IP/IT topics at conferences and seminars in Germany and abroad.
A multinational pharmaceutical company in the redesign and negotiation of numerous contracts (manufacturing, distribution, quality, pharmacovigilance, etc.) in connection with a global 'portfolio swap'.
A leading German biotechnology company in a licensing and participation agreement with an American pharmaceutical company and in a licensing agreement with a French pharmaceutical company in the field of cancer immunotherapy (two of the largest German biotechnology licensing deals in recent years)
A Berlin-based biotechnology company in several licensing collaborations with a Swiss pharmaceutical company in the field of human blood coagulation factors
A leading German online advertising company on numerous IP/IT, TSA and carve-out issues in connection with the acquisition of Europe's largest Internet customer portal
How to divorce amicably - Zur Gestaltung der Beendigungsszenarien im Lizenzdeal, Going Public - Life Sciences, 18. Jahrgang, 2016
Die Lizenz in der Insolvenz, Patentkommentar, transkript, 2016
Open Source Software - Grenzen und Vermeidung des viralen Effekts, Vortrag, 2016
Das Geheimnis in der Cloud - Überlegungen zu § 203 StGB, Vortrag, 2015
Patent- und Technologielizenzklauseln im F&E-Vertrag, Vortrag, 2015
Getting to Day 1 - Carve outs and product divestitures in the pharma sector, Vortrag, 2014
IT-Outsourcing und Cloud Computing, Vortrag, Otto Schmidt Verlag, 2013
Dawn-Raid-Basics - Grundwissen zu Durchsuchungen der Europäischen Kommission und des Bundeskartellamtes, Vortrag, 2013
What's the way the cookie crumbles? - Some observations on the state of implementation of the e-privacy directive in the UK and Germany, Vortrag, 2012
Der fliegende Gerichtsstand bei Internet-Sachverhalten, Leible/Sosnitza (Hrsg.), Onlinerecht 2.0: Alte Fragen – neue Antworten?, 2011
BGH 'Reifen Progressiv' - Zum dinglichen Charakter der Lizenz, Vortrag, 2010
Online Proxy Voting: A New Hope for Shareholder Democracy?, Stanford Law School, Thesis, Stanford Programme in international legal studies (SPILS), Stanford University, 2004